The only non-invasive way for physicians to assess for elevated left ventricular end diastolic pressure (LVEDP ≥ 20 mmHg) within minutes at point-of-care.
How it Works
FDA cleared
Under investigation to asses likelihood of diastolic dysfunction
Under investigation to asses likelihood of elevated pulmonary pressure
Millions of data points on cardiac and respiratory systems are analyzed by an FDA-cleared, machine-learned algorithm to predict likelihood of elevated LVEDP
Watch Video
Download Security Fact Sheet
CorVista® HF Analysis is available to physicians in a secure, web portal with minutes of the test being completed
Watch Video
